Show Notes
In this conversation, Maryrose Lyons chats with Doyin Badamosi, an AI innovator who has developed a system to assist GPs in detecting cancer earlier. Doyin shares his personal journey into medical technology, driven by family experiences with cancer. The discussion covers the impact of AI on healthcare, particularly in reducing reporting times for cancer diagnoses and enhancing the capabilities of general practitioners through data-driven insights. A hopeful listen for anyone who has been touched by cancer.
Find out more about Durotimi AI: https://www.durotimi.com/ Follow Doyin on LinkedIn: https://www.linkedin.com/in/doyinbademosi/ Hosted on Acast. See acast.com/privacy for more information.
More from Chatting GPT
If you are on Claude Pro and you have been stripping client details out of every document before you paste it, this one is for you.
Everyone hired you for your taste and experience. You just forgot that, and started believing the job was knowing the software.
Every company has a CFO. Almost none has anyone whose job is time.
Handing the AI programme to the CIO is the obvious move, and Stephen Redmond thinks it is the wrong one. AI is more than a technology rollout. It changes decision rights, it crosses every function from supply chain to sales, and it does not give the same answer twice, none of which sits comfortably inside IT.
What actually happens when your team uses AI to write a blog post, a tender or a report, and does the law now care? Alan Thornton, founder of the AI governance platform Tipcan Solutions, joins Maryrose Lyons to make the EU AI Act genuinely usable for built environment professionals.